Aug 11, 2025
Although there are no approved sarcopenia drugs at present, ongoing research is exploring possible pharmacological solutions. Investigational treatments include Selective Androgen Receptor Modulators (SARMs) and myostatin inhibitors, which aim to enhance muscle mass and function. Beyond non-pharmacological approach...
Read More...
Jul 28, 2025
Sarcopenia, often dubbed the “silent muscle thief,” is a progressive loss of skeletal muscle mass and strength that typically begins after the age of 30, accelerating after 60. Affecting up to 50% of adults over 80, sarcopenia isn’t just about frailty—it’s linked to increased risks of falls, fractures, loss of inde...
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
BYSANTI Approval Positions Vanda to Compete in the Antipsychotic Market
Mar 02, 2026
Newsletter/Whitepaper